推进登革热疫苗研发。 - Suppr

Suppr

超能文献

Advancing dengue vaccine development.

作者信息

Feinberg Mark B, Ahmed Rafi

机构信息

International AIDS Vaccine Initiative, New York, NY, USA.

Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.

出版信息

Science. 2017 Nov 17;358(6365):865-866. doi: 10.1126/science.aaq0215.

DOI:10.1126/science.aaq0215

PMID:29146795

Abstract

摘要

相似文献

Advancing dengue vaccine development.

Science. 2017 Nov 17;358(6365):865-866. doi: 10.1126/science.aaq0215.

Prospects for a dengue virus vaccine.

Nat Rev Microbiol. 2007 Jul;5(7):518-28. doi: 10.1038/nrmicro1690.

Implementing a dengue vaccination programme-who, where and how?

Trans R Soc Trop Med Hyg. 2018 Aug 1;112(8):367-368. doi: 10.1093/trstmh/try070.

Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.

Expert Rev Vaccines. 2016;15(4):467-82. doi: 10.1586/14760584.2016.1121814. Epub 2015 Dec 15.

Controversy over dengue vaccine risk.

Science. 2019 Sep 6;365(6457):961-962. doi: 10.1126/science.365.6457.961.

Call to action for dengue vaccine failure.

Emerg Infect Dis. 2013 Aug;19(8):1335-7. doi: 10.3201/eid1908.121864.

The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis.

Expert Rev Anti Infect Ther. 2017 Feb;15(2):111-119. doi: 10.1080/14787210.2017.1254550. Epub 2016 Nov 11.

Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus.

Front Immunol. 2019 Dec 16;10:2946. doi: 10.3389/fimmu.2019.02946. eCollection 2019.

Dengue vaccine: reliably determining previous exposure.

Lancet Glob Health. 2018 Aug;6(8):e830-e831. doi: 10.1016/S2214-109X(18)30295-X. Epub 2018 Jun 22.

Advances in dengue vaccine development.

Hum Vaccin. 2009 Aug;5(8):520-8. doi: 10.4161/hv.5.8.9008. Epub 2009 Aug 13.

引用本文的文献

Molecular ingredients of an immunogen for long-lasting IgG.

Front Immunol. 2025 Aug 19;16:1639371. doi: 10.3389/fimmu.2025.1639371. eCollection 2025.

Refining uncertainty about the TAK-003 dengue vaccine with a multi-level model of clinical efficacy trial data.

medRxiv. 2025 Aug 1:2025.07.31.25332513. doi: 10.1101/2025.07.31.25332513.

Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals?

Microbes Infect. 2023 Jan-Feb;25(1-2):105078. doi: 10.1016/j.micinf.2022.105078. Epub 2022 Nov 23.

In Silico Prediction of the Phosphorylation of NS3 as an Essential Mechanism for Dengue Virus Replication and the Antiviral Activity of Quercetin.

Biology (Basel). 2021 Oct 19;10(10):1067. doi: 10.3390/biology10101067.

Antiviral activity of betacyanins from red pitahaya () and red spinach () against dengue virus type 2 (GenBank accession no. MH488959).

Access Microbiol. 2019 Oct 31;2(1):acmi000073. doi: 10.1099/acmi.0.000073. eCollection 2020.

Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals.

bioRxiv. 2020 May 22:2020.05.13.092619. doi: 10.1101/2020.05.13.092619.

Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?

Front Immunol. 2019 Aug 27;10:1956. doi: 10.3389/fimmu.2019.01956. eCollection 2019.

Emerging and Reemerging Aedes-Transmitted Arbovirus Infections in the Region of the Americas: Implications for Health Policy.

Am J Public Health. 2019 Mar;109(3):387-392. doi: 10.2105/AJPH.2018.304849. Epub 2019 Jan 24.

The expanding role of mass spectrometry in the field of vaccine development.

Mass Spectrom Rev. 2020 Mar;39(1-2):83-104. doi: 10.1002/mas.21571. Epub 2018 May 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Advancing dengue vaccine development.

Science. 2017 Nov 17;358(6365):865-866. doi: 10.1126/science.aaq0215.

Prospects for a dengue virus vaccine.

Nat Rev Microbiol. 2007 Jul;5(7):518-28. doi: 10.1038/nrmicro1690.

Implementing a dengue vaccination programme-who, where and how?

Trans R Soc Trop Med Hyg. 2018 Aug 1;112(8):367-368. doi: 10.1093/trstmh/try070.

Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.

Expert Rev Vaccines. 2016;15(4):467-82. doi: 10.1586/14760584.2016.1121814. Epub 2015 Dec 15.

Controversy over dengue vaccine risk.

Science. 2019 Sep 6;365(6457):961-962. doi: 10.1126/science.365.6457.961.

Call to action for dengue vaccine failure.

Emerg Infect Dis. 2013 Aug;19(8):1335-7. doi: 10.3201/eid1908.121864.

The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis.

Expert Rev Anti Infect Ther. 2017 Feb;15(2):111-119. doi: 10.1080/14787210.2017.1254550. Epub 2016 Nov 11.

Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus.

Front Immunol. 2019 Dec 16;10:2946. doi: 10.3389/fimmu.2019.02946. eCollection 2019.

Dengue vaccine: reliably determining previous exposure.

Lancet Glob Health. 2018 Aug;6(8):e830-e831. doi: 10.1016/S2214-109X(18)30295-X. Epub 2018 Jun 22.

Advances in dengue vaccine development.

Hum Vaccin. 2009 Aug;5(8):520-8. doi: 10.4161/hv.5.8.9008. Epub 2009 Aug 13.

引用本文的文献

Molecular ingredients of an immunogen for long-lasting IgG.

Front Immunol. 2025 Aug 19;16:1639371. doi: 10.3389/fimmu.2025.1639371. eCollection 2025.

Refining uncertainty about the TAK-003 dengue vaccine with a multi-level model of clinical efficacy trial data.

medRxiv. 2025 Aug 1:2025.07.31.25332513. doi: 10.1101/2025.07.31.25332513.

Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals?

Microbes Infect. 2023 Jan-Feb;25(1-2):105078. doi: 10.1016/j.micinf.2022.105078. Epub 2022 Nov 23.

In Silico Prediction of the Phosphorylation of NS3 as an Essential Mechanism for Dengue Virus Replication and the Antiviral Activity of Quercetin.

Biology (Basel). 2021 Oct 19;10(10):1067. doi: 10.3390/biology10101067.

Antiviral activity of betacyanins from red pitahaya () and red spinach () against dengue virus type 2 (GenBank accession no. MH488959).

Access Microbiol. 2019 Oct 31;2(1):acmi000073. doi: 10.1099/acmi.0.000073. eCollection 2020.

Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals.

bioRxiv. 2020 May 22:2020.05.13.092619. doi: 10.1101/2020.05.13.092619.

Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?

Front Immunol. 2019 Aug 27;10:1956. doi: 10.3389/fimmu.2019.01956. eCollection 2019.

Emerging and Reemerging Aedes-Transmitted Arbovirus Infections in the Region of the Americas: Implications for Health Policy.

Am J Public Health. 2019 Mar;109(3):387-392. doi: 10.2105/AJPH.2018.304849. Epub 2019 Jan 24.

The expanding role of mass spectrometry in the field of vaccine development.

Mass Spectrom Rev. 2020 Mar;39(1-2):83-104. doi: 10.1002/mas.21571. Epub 2018 May 31.